Who may participate

This study is seeking healthy adult (18 or older) male and female participants of non-childbearing potential. Participants must be healthy, meaning they will not have the condition for which this treatment is being developed and are in overall good health. You may not take part in this study if: 
 

  • Not willing or able to travel to our study facility in Brussels, Belgium or not able to comply with study appointments and procedures 
  • Your body mass index (BMI) is outside the range of 18-32 kg/m2 or your bodyweight <50 kg.    

 

There are other requirements for participation in this study. Please read attentively the Informed Consent Document (ICD), more explanation will be provided by the study staff during the screening process.  

Condition

Healthy

Age

From 18 years old

Sex

Male/female without childbearing potential

Each clinical study has its own guidelines for who can participate, called eligibility criteria. However, only the research study staff can determine if you qualify to enroll in the study.

What to expect

If this study may be a fit for you, you’ll be invited to a screening visit at our facility in Brussels, Belgium.  

If you choose to participate, you will be in the study for about 90 days, including the screening, 2 treatment periods and a follow-up call at the end of the study.    

Participants will be admitted to the clinical research unit (CRU) for Period 1 of 11 days and 10 nights, then re-admitted for Period 2 of 15 days and 14 nights.  

 

Throughout the study, staff will closely monitor your health status and collect data. 

 

You will not personally derive any benefit from your participation in this study, but the results obtained could be very important for the development of medicines and treatments which will benefit other people. 

View calendar

How long is the study?

90 days

Compensation

Up to € 6840,00 plus travel fees

Long-term follow-up

A follow-up call at the end of the study